
Loading, please wait...

Loading, please wait...

Protein homeostasis, or proteostasis, remains essential for maintaining skeletal muscle integrity throughout a patient's life. However, its disruption serves as a central feature of aging-related sarcopenia. Researchers now recognize that aging skeletal muscle proteostasis involves complex interactions within the ubiquitin-proteasome system (UPS). This system acts as the primary pathway for selective protein degradation in muscle fibers. Unfortunately, its regulation during physiological aging remains incompletely understood. Consequently, clinicians must look beyond traditional markers to understand how muscle mass declines in the elderly.
Most clinical studies focus on muscle-specific E3 ubiquitin ligases, particularly MuRF1 and MAFbx/atrogin-1. These enzymes serve as reliable molecular markers for muscle atrophy because they flag proteins for degradation. However, current evidence suggests that changes in E3 ligase expression do not consistently correspond to actual proteasome activity. This disconnect indicates a gap between ubiquitination signals and the proteolytic capacity of the aging muscle. Therefore, relying solely on these markers may lead to an incomplete assessment of muscle health.
Deubiquitinating enzymes (DUBs) represent a crucial yet poorly understood regulatory layer in muscle aging. While E3 ligases add ubiquitin tags to proteins, DUBs remove them, effectively reversing the signal for degradation. Furthermore, specific DUBs like USP19 and USP14 appear to be induced during various forms of muscle wasting. This multi-layered regulation suggests that aging skeletal muscle proteostasis is not just about increased degradation. Instead, it involves a complex dysregulation of the entire proteostasis network. Understanding how these enzymes balance protein turnover is vital for developing future therapies for sarcopenia.
A more integrated evaluation of all UPS components is required to fully understand protein turnover in aging tissue. Current evidence indicates that different muscles and conditions regulate these components in distinct ways. Moreover, sarcopenia prevalence in India ranges significantly, with some studies reporting rates as high as 39.2% among the elderly. Given this high burden, moving beyond single-marker interpretations is essential. Clinicians should consider the combined activity of E3 ligases, DUBs, and the proteasome itself when evaluating muscle loss.
The ubiquitin-proteasome system (UPS) is the main pathway responsible for identifying and degrading selective proteins to maintain muscle integrity and health.
There is often a disconnect between the signals sent by E3 ligases and the actual activity of the proteasome, meaning protein tagging does not always lead to immediate degradation.
DUBs are enzymes that remove ubiquitin tags from proteins. They act as a regulatory layer that can prevent protein degradation, but their dysregulation can contribute to muscle wasting.
Disclaimer: This content is for informational and educational purposes only. It does not constitute professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with any questions you may have regarding a medical condition. Refer to the latest local and national guidelines for clinical practice.
References

Read summarized clinical updates, watch expert medical content, and earn CME certifications right from your smartphone.


This article examines how the multi-layered dysregulation of the ubiquitin-proteasome system (UPS) drives sarcopenia by disrupting muscle protein homeostasi...
5 months ago

Review how tailored exercise programs benefit frail older patients with heart failure. Explore pathophysiological mechanisms, individualized training prescriptions, and strategies to overcome adherence barriers in clinical practice.
Today

Leucine Rich Bio has introduced South Asia's first comprehensive vaginal microbiome test, BugSpeaks. By profiling microbial dysbiosis, pathogens, and antimicrobial resistance, this next-generation diagnostic platform provides clinicians with deeper insights into recurrent infections, fertility, and reproductive health.
Today

In high-risk pulmonary embolism complicated by severe anemia and active uterine bleeding, systemic thrombolysis is contraindicated. Large-bore aspiration thrombectomy provides rapid hemodynamic rescue without fibrinolysis, supported by inferior vena cava filter placement and multidisciplinary critical care.
Today

This comparative study evaluates posterior labral tears with and without glenohumeral instability, highlighting distinct demographic patterns, MRI underestimation in stable shoulders, and successful arthroscopic repair outcomes.
Today

A clinical study demonstrates that early intervention with tocilizumab, either as monotherapy or bridged with corticosteroids, achieves significant proptosis reduction and resolves active inflammation in treatment-naive thyroid eye disease.
Today